Cargando…
IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a si...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716793/ https://www.ncbi.nlm.nih.gov/pubmed/26677135 http://dx.doi.org/10.3892/ijmm.2015.2433 |
_version_ | 1782410590070767616 |
---|---|
author | GAO, QIYUE LIU, YANG WU, YAN ZHAO, QIANG WANG, LIJUN GAO, SHANSHAN WEN, WEN ZHANG, WEIPING GUO, NING ZHOU, JUAN YUAN, ZUYI |
author_facet | GAO, QIYUE LIU, YANG WU, YAN ZHAO, QIANG WANG, LIJUN GAO, SHANSHAN WEN, WEN ZHANG, WEIPING GUO, NING ZHOU, JUAN YUAN, ZUYI |
author_sort | GAO, QIYUE |
collection | PubMed |
description | Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a signature molecule of inflammation, could be intensified by IL-17 when combined with IFN-γ. Thus, we explored the roles and underlying mechanisms of IL-17 and IFN-γ in the regulation of NOS2 expression in RAW 264.7 cells using qPCR, western blot analysis, colorimetric analysis, ChIP assay and statistical analysis. Although IL-17 alone did not induce NOS2 expression or nitric oxide (NO) production, as shown by western blot analysis and colorimetric analysis, it intensified IFN-γ-induced NOS2 upregulation and NO production in RAW 264.7 cells. The alteration of relevant transcription factors demonstrated that a combination of IFN-γ and IL-17 enhanced Tyr701-phosphorylated signal transducer and activator of transcription 1 [p-STAT1(Y701)] and nuclear factor-κB (NF-κB) activation, nuclear translocations and their binding to the NOS2 promoter, compared with IFN-γ alone, as illustrated by the results of the western blot analysis and ChIP assay. Also, using the corresponding inhibitors of STAT1 and NF-κB, we noted downregulation of the expression of NOS2 induced by IFN-γ alone or in combination with IL-17, respectively. In addition, IFN-γ increased phosphorylated (p-)p38 mitogen-activated protein kinase (MAPK), and accelerated the activation of the NF-κB pathway and the expression of NOS2, but phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) was reduced by treatment with IFN-γ and IL-17. IL-17 intensified the activation of the NF-κB pathway and NOS2 upregulation induced by IFN-γ by increasing the phosphorylation of p38 MAPK and limiting the phosphorylation of ERK1/2. Taken together, these results suggest that IL-17 intensified IFN-γ-induced NOS2 upregulation and NO production by increasing the transcription activity of p-STAT1(Y701) and NF-κB in RAW 264.7 cells. Further activation of the NF-κB pathway induced by IL-17 relied on enhanced phosphorylation of p38 MAPK and decreased phosphorylation of ERK1/2. The mechanism suggested in this study provides novel information which may be used for anti-inflammatory therapy with IL-17. |
format | Online Article Text |
id | pubmed-4716793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-47167932016-01-22 IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB GAO, QIYUE LIU, YANG WU, YAN ZHAO, QIANG WANG, LIJUN GAO, SHANSHAN WEN, WEN ZHANG, WEIPING GUO, NING ZHOU, JUAN YUAN, ZUYI Int J Mol Med Articles Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a signature molecule of inflammation, could be intensified by IL-17 when combined with IFN-γ. Thus, we explored the roles and underlying mechanisms of IL-17 and IFN-γ in the regulation of NOS2 expression in RAW 264.7 cells using qPCR, western blot analysis, colorimetric analysis, ChIP assay and statistical analysis. Although IL-17 alone did not induce NOS2 expression or nitric oxide (NO) production, as shown by western blot analysis and colorimetric analysis, it intensified IFN-γ-induced NOS2 upregulation and NO production in RAW 264.7 cells. The alteration of relevant transcription factors demonstrated that a combination of IFN-γ and IL-17 enhanced Tyr701-phosphorylated signal transducer and activator of transcription 1 [p-STAT1(Y701)] and nuclear factor-κB (NF-κB) activation, nuclear translocations and their binding to the NOS2 promoter, compared with IFN-γ alone, as illustrated by the results of the western blot analysis and ChIP assay. Also, using the corresponding inhibitors of STAT1 and NF-κB, we noted downregulation of the expression of NOS2 induced by IFN-γ alone or in combination with IL-17, respectively. In addition, IFN-γ increased phosphorylated (p-)p38 mitogen-activated protein kinase (MAPK), and accelerated the activation of the NF-κB pathway and the expression of NOS2, but phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) was reduced by treatment with IFN-γ and IL-17. IL-17 intensified the activation of the NF-κB pathway and NOS2 upregulation induced by IFN-γ by increasing the phosphorylation of p38 MAPK and limiting the phosphorylation of ERK1/2. Taken together, these results suggest that IL-17 intensified IFN-γ-induced NOS2 upregulation and NO production by increasing the transcription activity of p-STAT1(Y701) and NF-κB in RAW 264.7 cells. Further activation of the NF-κB pathway induced by IL-17 relied on enhanced phosphorylation of p38 MAPK and decreased phosphorylation of ERK1/2. The mechanism suggested in this study provides novel information which may be used for anti-inflammatory therapy with IL-17. D.A. Spandidos 2016-02 2015-12-11 /pmc/articles/PMC4716793/ /pubmed/26677135 http://dx.doi.org/10.3892/ijmm.2015.2433 Text en Copyright: © Gao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles GAO, QIYUE LIU, YANG WU, YAN ZHAO, QIANG WANG, LIJUN GAO, SHANSHAN WEN, WEN ZHANG, WEIPING GUO, NING ZHOU, JUAN YUAN, ZUYI IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title | IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title_full | IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title_fullStr | IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title_full_unstemmed | IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title_short | IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB |
title_sort | il-17 intensifies ifn-γ-induced nos2 upregulation in raw 264.7 cells by further activating stat1 and nf-κb |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716793/ https://www.ncbi.nlm.nih.gov/pubmed/26677135 http://dx.doi.org/10.3892/ijmm.2015.2433 |
work_keys_str_mv | AT gaoqiyue il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT liuyang il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT wuyan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT zhaoqiang il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT wanglijun il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT gaoshanshan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT wenwen il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT zhangweiping il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT guoning il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT zhoujuan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb AT yuanzuyi il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb |